CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 565967-566069 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Some were injected with 0.9% saline solution and were also treated with DX (group 3) or not (group 4).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T23539","span":{"begin":0,"end":102},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T23539","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T287","span":{"begin":0,"end":102},"obj":"Sentence"}],"attributes":[{"subj":"T287","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93e5ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecd993"}]}]}}